Loading...
•
Jun 30, 2020
ICU Medical Q2 2020 Earnings Report
Second quarter results reflected strong demand for infusion pumps due to the COVID-19 pandemic and were generally in line with expectations.
Key Takeaways
ICU Medical announced second-quarter revenue of $303.4 million, compared to $312.3 million in the same period last year. GAAP net income was $18.9 million, or $0.88 per diluted share, as compared to GAAP net income of $22.8 million, or $1.06 per diluted share, for the second quarter of 2019.
Second quarter revenue was $303.4 million, compared to $312.3 million in the same period last year.
GAAP gross profit for the second quarter of 2020 was $106.3 million, as compared to $103.9 million in the same period last year.
GAAP gross margin for the second quarter of 2020 was 35%, as compared to 33% in the same period last year.
Adjusted diluted earnings per share for the second quarter of 2020 were $1.65 as compared to $1.99 for the second quarter of 2019.
Revenue by Segment
Forward Guidance
This press release contains forward-looking statements that are subject to risks and uncertainties, and actual results and events could differ materially from those stated in the forward-looking statements.
Challenges Ahead
- decreased demand for the Company's products
- decreased free cash flow
- the inability to recapture conversion delays or part/resource shortages on anticipated timing, or at all
- changes in product mix
- increased competition from competitors
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...